 |
인쇄하기
취소
|
KFDA approves Bausch & Lomb’s loteprednol etabonate 0.5%, 0.2%
The Korea Food and Drug Administration has given a green light to Bausch & Lomb’s loteprednol etabonate 0.5% and 0.2% for treatment of allergic disease.
Loteprednol etabonate 0.2% ophthalmic suspension is used for the symptomatic relief of seasonal allergic (hay fever, pollinosis) conjunctivitis. Loteprednol etabonate 0.5% ophthalmic suspension also is used for the symptomatic relief of alle...
Loteprednol etabonate 0.2% ophthalmic suspension is used for the symptomatic relief of seasonal allergic (hay fever, pollinosis) conjunctivitis. Loteprednol etabonate 0.5% ophthalmic suspension also is used for the symptomatic relief of alle...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.